CASA – Carpal Arch Space Augmentation
University of Arizona researchers have developed an affordable precision brace technology for carpal tunnel relief, delivering targeted compression and customized comfort to transform hand health.
The Problem
Carpal tunnel syndrome affects millions globally. The current challenge in Carpal Tunnel Syndrome (CTS) treatment lies in the century-old surgical approach of surgically transecting the transverse carpal ligament (TCL), disrupting wrist function and lacking fundamental advancements.
The Solution
Our technology revolutionizes carpal tunnel syndrome (CTS) treatment by introducing a non-invasive, biomechanical approach that focuses on narrowing the carpal arch width, increasing arch height, and decompressing the median nerve, addressing the limitations of century-old surgical methods and providing a scientifically validated alternative backed by extensive experimental studies, geometric modeling, finite element analysis, and clinical research.
The Opportunity
With the global prevalence of carpal tunnel syndrome affecting millions, CASA presents a market opportunity of ~$2B. This technology can be sold online or over the counter. This is a transformative opportunity with its novel non-invasive wearable device designed for effective median nerve decompression. This innovation addresses a substantial market need, providing a breakthrough solution for individuals seeking advanced and convenient management of carpal tunnel syndrome symptoms.
Status
The research team is currently in the prototype phase, advancing towards clinical trials. Early trials show significant relief for patients and indicates a potential alternative to more invasive treatments for patients.
Meet the Team
Zong-Ming Li PhD
College of Engineering
Derick Maggard
Tech Launch Arizona